Innovation and accuracy are crucial for advancement in the fast-paced domains of healthcare and life sciences. To comply with stringent standards, controlling contamination and guaranteeing the sterility of facilities have become major issues.
Indigo Pharmaceutical has unveiled a new fully automated disinfection technology in response to the need to swiftly generate huge numbers of medications.
Image Credit: Gorodenkoff/Shutterstock.com
Pharmaceutical manufacturing automation
American patients will greatly benefit from Indigo Pharmaceutical's expansion of pharmaceutical manufacturing in the US. Indigo is committed to offering pharmaceutical manufacturing services, including a 503b outsourced manufacturing facility specializing in sterile pharmaceuticals.
A vast quantity of medications are produced for delivery to physicians and healthcare facilities around the country, and these operations are subject to strict cGMP, GMP, GLP, and ISO standards.
The facility has been constructed to maintain an entirely isolated atmosphere to prevent human contact throughout pharmaceutical manufacturing. Every piece of equipment is automated and connected to the building management system.
Introducing the SteraMist Hybrid
The SteraMist Hybrid, a new iHP decontamination system, has been installed at Indigo Pharmaceutical's plant in response to the demand for automated disinfection and cost-effectiveness.
The SteraMist Hybrid combines the portability of the SteraMist Environment System with integrated facility disinfection. The Environment System generator is connected to permanent stainless steel ceiling applicators placed in any area via a centralized hub equipped with harting connectors.
Indigo deployed six permanently mounted stainless steel iHP applicators in key locations in four distinct ISO compounding rooms. Outside the facility's pharmaceutical manufacturing operations are two centralized hubs, each with three connections, for six connections.
By simply moving and connecting the portable SteraMist Environment System to these hubs, three full-room decontamination cycles can be started simultaneously.
By implementing an automatic disinfection nightly routine, Indigo Pharmaceuticals has ensured that the SteraMist Hybrid operates frequently to thoroughly clean the facility and adhere to strict regulations.
SteraMist continues to lead the way in innovation, creating cutting-edge iHP systems to satisfy customers' needs with automated disinfection. By introducing a varied product line intended to cover a range of needs, SteraMist has simplified its products and ensured the timely fulfillment of customer demands.
About SteraMist Disinfection and Decontamination Technology
SteraMist is a global line of powerful disinfection and decontamination products and services that utilizes patented ionized Hydrogen Peroxide (iHP) technology.
Our scientific expertise, innovation, and dedication to creating a safer world through cutting-edge iHP technology allow SteraMist to serve our customers and industries with trusted products, leading to a smarter way to decontaminate and control infectious diseases.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.